Authors
Loading...
Qualitative and quantitative analysis identifies cardiotoxicity and mutagenicity risks of phencyclidine analogs, suggesting need for risk assessment.
Noga et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: